VIDEO: People with Parkinson’s freeze for ‘mannequin challenge’
Author: Almaz OhenePublished: 5 January 2017
Prep: Cook: Serves:
Parkinson’s campaigners worldwide are taking up the ‘mannequin challenge’ – the latest social media trend to sweep the web – to show that ‘freezing’ is part of everyday life for many people with the condition
To share the reality of ‘freezing of gait’, major Parkinson’s organisations around the world have filmed their own versions of the popular social media trend, the #MannequinChallenge. Here are three of the most popular – from Parkinson’s UK, the Parkinson Voice Project in the US and Parkinson’s NSW in Australia.
It launched a campaign featuring four videos showing people unable to move in everyday scenarios such as crossing the street, making a cup of tea and answering the front door.
The emotive messaging asks viewers to “Donate. Now. So their challenge can end.”
2. Parkinson Voice Project
Patients at the Parkinson Voice Project’s clinic in Texas, US, showed viewers the interactive and dynamic nature of their regular speech therapy classes, as they pause for a minute for the camera stunt.
3. Parkinson’s NSW
The Australian organisation took a different approach and focused on people with Parkinson’s tremors among those frozen in time.
4. Vlaamse Parkinson Liga
This challenge was an initiative by a group from Ghent, Belgium who are part of the Vlaamse Parkinson Liga (VPL), the Flemish Parkinson’s disease association. They wanted to highlight the fact that although Parkinson’s patients freeze due to stability problems, it’s also difficult to freeze on demand. The organisation’s president is Yves Meersman, who is also the lead chef behind the Parki’s Kookatelier project.
First it was ‘planking’, then came the ice bucket challenge, and now ‘mannequin challenge’ videos are sweeping the web – a viral internet video trend where people remain frozen in action like mannequins while a moving camera films them.
Women worldwide pose in their heels for Parkinson’s awareness
Young onset PD awareness campaign ‘Heels On Head Up’
6 days ago
Parkinson’s gene therapy could improve motor symptoms
UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s. The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences. The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function. Professor Thomas Foltynie, neurology consultant at University College London Hospitals – which is carrying out the research alongside University College London – said: “Genes that increase the production of dopamine could help alleviate the symptoms of Parkinson’s disease, potentially with fewer side effects than traditional drug treatments, by targeting only the areas of the brain that are lacking in dopamine.”
Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs
Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions. The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year. Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising…
AI technology could diagnose Parkinson’s in less than three minutes
Chinese technology enterprise Tencent has partnered with UK healthcare company Medopad and the Centre of Excellence in Parkinson’s and Movement Disorders at Kings College Hospital, UK, to create artificial intelligence (AI) software that may be able to diagnose Parkinson’s in less than three minutes. The team trained the AI system by analysing video footage of people with Parkinson’s, and believes it will help doctors identify and diagnose the condition at a far earlier stage. In addition, it is hoped the test could be carried out remotely using smartphone technology. Dan Vahdat, CEO and Co-founder of Medopad, said: “Our partnership with Tencent comes from a shared vision to change the future of healthcare as we know it. “In combining Medopad’s medical expertise and Tencent’s technical capabilities, we hope to provide the technology needed to support clinicians to predict preventable complications for people with Parkinson’s disease.”